Table 4:

Characteristics of participants included in the assessment of concordance between prenatal prognosis and postnatal neurodevelopmental outcome

Characteristic(n = 104)GA <25 Weeks (n = 50)GA ≥25 Weeks (n = 54)
GA at fetal MR imaging (range)  (median) (IQR) (wk)19.00–39.43 (26.1 [21.8, 31.9])19.00–24.43 (21.7 [21.0, 23.0])25.00–39.43 (31.9 [29.6–34.0])
Maternal age at fetal MR imaging  (range) (median) (IQR) (yr)16.00–41.00 (31.0 [28.0–33.0])16.00–41.00 (30.0 [28.0–32.0])17.00–41.00 (31.0 [28.0–34.0])
Age at postnatal visit (range) (median) (IQR) (yr)1.00–10.42 (3.0 [1.9–5.9])1.00–8.92 (2.8 [1.7–5.1])1.00–10.42 (3.8 [2.0–6.0])
Brain region (No.) (%)
 Ventriculomegaly32 (30.8%)17 (34.0%)15 (27.8%)
  Mild20 (19.2%)12 (24.0%)8 (14.8%)
  Moderate5 (4.8%)3 (6.0%)2 (3.7%)
  Severe7 (6.7%)2 (4.0%)5 (9.3%)
 Posterior fossa19 (18.3%)7 (14.0%)12 (22.2%)
 Corpus callosum11 (10.6%)2 (4.0%)9 (16.7%)
 Sulcation/migration8 (7.7%)5 (10.0%)3 (5.6%)
 Normal28 (26.9%)18 (36.0%)10 (18.5%)
 Space4 (3.8%)1 (2.0%)3 (5.6%)
 Vascular anomaly1 (1.0%)0 (0.0%)1 (1.9%)
 Hemorrhage1 (1.0%)0 (0.0%)1 (1.9%)